Objective: To investigate whether members of a transfusion-linked cohort (the Sydney Bloodbank Cohort) infected with a nef-deleted strain of HIV-1 could be differentiated from individuals infected with wild-type strains of HIV-1 by characterizing the Nef antibody response of cohort members.
Design: Retrospective and prospective analysis of the nef gene sequence and the antibody response to Nef peptides in HIV-infected subjects.
Methods: Plasma was obtained from all individuals of the Sydney cohort, and from a variety of HIV-1-infected and uninfected controls. Antibodies recognizing full-length recombinant HIV-1NL43 Nef protein and synthetic peptide analogues were assessed by enzyme-linked immunosorbent assay.
Results: All 34 individuals infected with wild-type HIV-1 had antibodies reacting with full-length Nef protein as well as with a series of synthetic peptides (6-23-mers) spanning most of the Nef protein of HIV-1NL43. Although the HIV-1 quasispecies infecting the Sydney cohort had a consensus deletion of the nef gene corresponding to amino-acids 165-206, HIV-1 strains from individual members of the cohort had additional deletions comprising up to 80% of the nef gene. Members of the cohort had antibodies to peptides homologous to all regions of the Nef protein tested, except for a single peptide (amino-acids 162-177) that lies within the consensus nef deletion for the cohort quasispecies.
Conclusion: These data show that nef-deleted strains of HIV-1 can be detected serologically. In the Sydney cohort, detection of antibodies to all regions of Nef tested, except that corresponding to amino-acids 162-177, suggests that observed deletions outside this domain occurred after this virus had infected these subjects and stimulated an immune response. A Nef peptide serological assay may be useful for identifying further examples of individuals infected with nef-deleted, attenuated HIV-1 quasispecies and for assessing the evolution of those variants in vivo.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00002030-199806000-00003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Construction of a Macrophage-Tropic Subtype C HIV-1-mGreenLantern Reporter Virus for Studies on HIV-1 Replication and the Impact of Methamphetamine.
Viruses
November 2024
Departments of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
HIV-1 subtype C viruses are responsible for 50% of global HIV burden. However, nearly all currently available reporter viruses widely used in HIV research are based on subtype B. We constructed and characterized a replication-competent HIV-1 subtype C reporter virus expressing mGreenLantern.
View Article and Find Full Text PDFGonadal sex reversal at single-cell resolution in Znrf3-deficient mice.
Development
December 2024
MRC Mammalian Genetics Unit, MRC Harwell Institute, Didcot, Oxfordshire OX11 0RD, UK.
Article Synopsis
- The anti-WNT factor ZNRF3 is crucial for determining gonadal sex, as XY mice lacking it show variable ovarian tissue development during fetal stages.
- Researchers used single-cell RNA sequencing to investigate how ZNRF3 deficiency affects cell development in the gonads, revealing failures in the proper differentiation of Sertoli and granulosa cells.
- The study finds that without ZNRF3, there is significant disruption in the expected testicular cell fate, leading to a mix of cellular identities that complicate the traditional understanding of sexual differentiation.
lncRNA-NEF regulates hepatic stellate cells proliferation, cell cycle, apoptosis and ECM synthesis through the ERK1/2/c-Fos axis.
Exp Cell Res
January 2025
Gansu University of Chinese Medicine, Lanzhou, China; Department of Gastroenterology, The 940th Hospital of Joint Service Logistics Support Force of PLA, Lanzhou, China. Electronic address:
In this study, we investigated the role of lncRNA-NEF in modulating hepatic stellate cell (HSC) activation, a key process in liver fibrosis. Using the GSE78160 dataset, we identified lncRNA-NEF as downregulated in liver cirrhosis patients. Gene Ontology and KEGG analyses implicated it in transcriptional regulation and cell cycle control.
View Article and Find Full Text PDFComparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 Antigen.
Protein Pept Lett
January 2025
Department of Hepatitis, AIDS and Blood-borne Diseases, Pasteur Institute of Iran. Tehran, Iran.
Background: There have been great efforts in vaccine design against HIV-1 since 1981. Various approaches have been investigated, including optimized delivery systems and effective adjuvants to enhance the efficacy of selective antigen targets. In this study, we evaluated the efficiency of IMT-P8 and LDP12 cell penetrating peptides in eliciting immune responses against HIV-1 Nef-MPER-V3 fusion protein as an antigen candidate.
View Article and Find Full Text PDFThe role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women.
bioRxiv
November 2024
Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
HIV-1 Nef mediates immune evasion and viral pathogenesis in part through downregulation of cell surface cluster of differentiation 4 (CD4) and major histocompatibility complex class I (MHC-I) on infected cells. While Nef function of circulating viral populations found early in infection has been associated with reservoir size in early-treated cohorts, there is limited research on how its activity impacts reservoir size in people initiating treatment during chronic infection. In addition, there is little research on its role in persistence of viral variants during long-term antiretroviral therapy (ART).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!